Discover 489 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 489
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Providence RI, Boston MA, Hartford CT, New Haven CT,
Sponsor: Translational Sciences, Inc.
Sex: All
Age: 18+
Code: NCT05948566
Phase 2, Recruiting
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: Providence RI, New Brunswick NJ
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT04792502
Phase 2, Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Get alerts for new trials in your area by subscribing now
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
for
Melanoma
Location: Providence RI, New Haven CT, Paramus NJ, Hackensack NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06246916
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New Haven CT, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Providence RI, New York NY, Fairfax VA, Toronto,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05765851
Phase 1, Recruiting
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
for
Meningioma
Location: Providence RI, Boston MA, New York NY, Fairfax VA,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07428616
Phase 2, Recruiting
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Providence RI, The Bronx NY, Montreal, Toronto,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase 2, Recruiting
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
Location: Providence RI, New York NY, Fairfax VA, Cleveland OH,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06084481
Phase 1, Recruiting
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
for
Cancer Harboring BRAF Alterations, HGG, LGG, Solid Tumors
Location: Providence RI, Boston MA, Norwalk CT, New York NY,
Sponsor: Fore Biotherapeutics
Sex: All
Age: 8+
Code: NCT05503797
Phase 2, Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Location: Providence RI, Boston MA, Burlington MA, New Haven CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06119581
Phase 3, Recruiting
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Providence RI, Boston MA, New Haven CT, New York NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT03972657
Phase 1, Phase 2, Recruiting
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
for
Neoplasms, Child, Adolescent
Location: Providence RI, New York NY, Washington D.C. DC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 1 - 39
Code: NCT05999994
Phase 2, Recruiting
A New Clinical Model for the Engagement of Latinx Youth With Suicidal Behavior